reported that one patient who developed severe CRS associated with HLH following CD19 CAR therapy for ALL was found to carry a mutation in the perforin (PRF1) gene, which predisposes to HLH (52). This evidence concerns the gene PRF1 and acute lymphoblastic leukemia.